Status:
UNKNOWN
Can Virtual Reality Reduce Depression and Agitation in Older Adults With Moderate to Severe Dementia?
Lead Sponsor:
Western University, Canada
Conditions:
Moderate Dementia
Severe Dementia
Eligibility:
All Genders
65-110 years
Phase:
NA
Brief Summary
Dementia is a term used to describe a collection of symptoms including memory loss, problems with reasoning and communication, and a reduction in a person's ability to carry out daily activities. The ...
Detailed Description
Dementia is a term used to describe a collection of symptoms including memory loss, problems with reasoning and communication, and a reduction in a person's ability to carry out daily activities such ...
Eligibility Criteria
Inclusion
- Resident of Henley Place, Henley House, and Burton Manor
- Cognitive Performance Scale score between 3 to 5.
Exclusion
- Without a medical diagnosis of dementia,
- Diagnosis of epilepsy,
- Those who are blind,
- Residents at end of life,
- Unable to communicate in English,
- Residents whose substitute decision-maker is from the Public Trustee and Guardian office of Ontario.
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 27 2020
Estimated Enrollment :
266 Patients enrolled
Trial Details
Trial ID
NCT04347668
Start Date
April 1 2019
End Date
September 27 2020
Last Update
April 15 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Burton Manor
Brampton, Ontario, Canada, L6Y 5P3
2
Henley Place
London, Ontario, Canada, N5X 0K2
3
Henley House
Saint Catherines, Ontario, Canada, L2N 7T2